IO BIOTECH INC. - COM
1.0600
07-October-24 15:59:55
15 minutes delayed
Stocks
-0.0900
-7.83%
Today's range
1.0600 - 1.1700
ISIN
N/A
Source
NASDAQ
-
01 Nov 2023 08:30:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 01:00:00 By Nasdaq GlobeNewswire
-
03 Oct 2023 16:30:00 By Nasdaq GlobeNewswire
-
12 Sep 2023 08:05:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Participation in Upcoming Investor Conferences
06 Sep 2023 08:35:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 Second Quarter Results
11 Aug 2023 08:30:00 By Nasdaq GlobeNewswire
-
IO Biotech Appoints Heidi Hunter to its Board of Directors
11 Aug 2023 08:05:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023
08 Aug 2023 08:05:00 By Nasdaq GlobeNewswire
-
IO Biotech, Inc. Announces $75 Million Private Placement Financing
07 Aug 2023 08:30:12 By Nasdaq GlobeNewswire
-
28 Jul 2023 08:05:00 By Nasdaq GlobeNewswire
-
25 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
18 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
14 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
01 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
IO Biotech to Present at the Jefferies Healthcare Conference
30 May 2023 16:35:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 First-Quarter Results
11 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 Mar 2023 16:11:47 By Nasdaq GlobeNewswire
-
IO Biotech to Participate in March 2023 Investor Conferences
22 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of Devin Smith as General Counsel
23 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
IO Biotech Provides Business Update
09 Jan 2023 07:05:46 By Nasdaq GlobeNewswire